De-Escalation Surgery in cT3-4 Breast Cancer Patients after Neoadjuvant Therapy: Predictors of Breast Conservation and Comparison of Long-Term Oncological Outcomes with Mastectomy.
Corrado TinterriErika BarbieriAndrea SagonaAlberto BottiniGiuseppe CanaveseDamiano GentilePublished in: Cancers (2024)
BCS after NAT is a feasible and safe option for patients with cT3-4 BC, without adversely affecting long-term oncological outcomes. Identifying predictors of breast conservation can guide surgical decision-making, ensuring that patients receive optimal treatment.
Keyphrases
- rectal cancer
- end stage renal disease
- computed tomography
- decision making
- image quality
- ejection fraction
- minimally invasive
- newly diagnosed
- contrast enhanced
- radical prostatectomy
- dual energy
- chronic kidney disease
- lymph node
- locally advanced
- peritoneal dialysis
- prostate cancer
- positron emission tomography
- robot assisted
- randomized controlled trial
- clinical trial
- metabolic syndrome
- coronary artery disease
- squamous cell carcinoma
- magnetic resonance
- bone marrow
- patient reported outcomes
- insulin resistance
- patient reported
- weight loss